Access Bio, Inc.

Access Bio, Inc. — FDA 510(k) Submissions

Access Bio, Inc. has submitted 3 FDA 510(k) premarket notifications since 2020, of which 3 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Devices Detecting Influenza A, B, And C Virus Antigens, Over-the-counter Covid-19 Antigen Test, Multi-analyte Respiratory Virus Antigen Detection Test . Use the specialty filter in the sidebar to narrow results.